These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. An assessment of erythroid response to epoetin alpha as a single agent versus in combination with granulocyte- or granulocyte-macrophage-colony-stimulating factor in myelodysplastic syndromes using a meta-analysis approach. Mundle S, Lefebvre P, Vekeman F, Duh MS, Rastogi R, Moyo V. Cancer; 2009 Feb 15; 115(4):706-15. PubMed ID: 19152429 [Abstract] [Full Text] [Related]
44. Neutrophil recovery time and adverse side effects in acute leukemia patients treated with intensive chemotherapy and concomitant G or GM-CSF. Alvarado Ibarra ML, Borbolla Escoboza JR, López-Hernández MA, González-Avante CM, FloresChapa JD, Trueba Christy E, Anaya Cuellar I. Rev Invest Clin; 1999 Feb 15; 51(2):77-80. PubMed ID: 10410585 [Abstract] [Full Text] [Related]
50. A randomized trial comparing the combination of granulocyte-macrophage colony-stimulating factor plus granulocyte colony-stimulating factor versus granulocyte colony-stimulating factor for mobilization of dendritic cell subsets in hematopoietic progenitor cell products. Lonial S, Hicks M, Rosenthal H, Langston A, Redei I, Torre C, Duenzl M, Feinstein B, Cherry J, Waller EK. Biol Blood Marrow Transplant; 2004 Dec 15; 10(12):848-57. PubMed ID: 15570253 [Abstract] [Full Text] [Related]
52. [Granulocyte-macrophage colony-stimulating factor in the treatment of secondary bone marrow suppression in patients with lymphoma. Preliminary report]. Avilés A, Díaz-Maqueo JC, Talavera A, García EL. Arch Invest Med (Mex); 1990 Dec 15; 21(2):133-7. PubMed ID: 2103701 [Abstract] [Full Text] [Related]
57. [Indications of G-CSF in patients with drug-induced agranulocytosis]. Takeda R, Utsugisawa T, Murai K, Narigasawa Y, Miyairi Y, Kuriya S. Rinsho Ketsueki; 1993 Sep 15; 34(9):997-1001. PubMed ID: 7693988 [Abstract] [Full Text] [Related]
58. Chemotherapy and granulocyte-colony stimulating factor for non-Hodgkin's lymphoma of the head and neck. Tsuge I, Suzuki K, Moribe K, Motai H, Kimura T, Umeda K, Kobayashi T, Yokota A, Hondo J, Baba S. Acta Otolaryngol Suppl; 1996 Sep 15; 525():129-34. PubMed ID: 8908287 [Abstract] [Full Text] [Related]
59. The use of granulocyte colony-stimulating factor does not appear to reduce recovery time in penicillin-related agranulocytosis during the treatment of endocarditis. Figueira-Coelho J, Pereira O, Picado B, Mendonça P, Neves-Costa J. J Heart Valve Dis; 2010 Nov 15; 19(6):810-1. PubMed ID: 21214116 [No Abstract] [Full Text] [Related]
60. Treatment of antithyroid drug-induced agranulocytosis by granulocyte colony-stimulating factor: a case of primum non nocere. Hirsch D, Luboshitz J, Blum I. Thyroid; 1999 Oct 15; 9(10):1033-5. PubMed ID: 10560960 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]